Skip to content
Screener

Cytek Biosciences, Inc. CTKB Service — Total revenue, net

Similar metrics at other companies

Evolus logo
EOLSService revenue — Total net revenues
$734K+6.7%
Enviri logo
NVRIProducts And Services, Service Revenue — Total revenues
$187.34M-40.7%
Kinetik Holdings logo
KNTKService revenue — Total revenues
$93.77M-26.7%
Viavi Solutions Inc. logo
VIAVService revenue — Total net revenue
$49.8M+15.0%
Intuit logo
INTUService — Total net revenue
$7.76B+11.3%
Sotera Health logo
SHCService — Total net revenues
$278.33M+8.2%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
(In thousands, except share and per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue, net:
Product$32,556$31,415$61,335$59,525
Service15,58414,18730,94027,534
Total revenue, net48,14045,60292,27587,059
Cost of sales:
Product12,88414,92128,80530,450
Service6,9166,81413,87612,585
Total cost of sales19,80021,73542,68143,035

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s service — total revenue, net?
Cytek Biosciences, Inc. (CTKB) reported service — total revenue, net of $15.58M in Q2 2026.
How has Cytek Biosciences, Inc.'s service — total revenue, net changed year-over-year?
Cytek Biosciences, Inc.'s service — total revenue, net increased by 9.8% year-over-year, from $14.19M to $15.58M.
What is the long-term trend for Cytek Biosciences, Inc.'s service — total revenue, net?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s service — total revenue, net has grown at a 61.4% compound annual growth rate (CAGR), from $8.43M to $57.26M.
What does service — total revenue, net mean?
This metric represents the total net revenue generated from service-related activities, including maintenance contracts, instrument repairs, and technical support. It reflects the company's ability to monetize its installed base of analytical instruments through recurring service agreements and on-demand support. Growth in this area indicates increasing customer adoption and long-term reliance on the company's technology ecosystem.

Ask your AI about Cytek Biosciences, Inc.'s service — total revenue, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude